Fitch revises Biocon Biologics outlook to Positive, affirms rating at BB-

Fitch Ratings revised Biocon Biologics Limited’s outlook to Positive, affirming its BB- rating, citing Biocon Limited’s improving financials and strong global biosimilars market position.​Read More